Form 8-A

 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-A

 

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR 12(g) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

 

AURIS MEDICAL HOLDING AG

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Switzerland   Not Applicable
(State of Incorporation or Organization)   (I.R.S. Employer Identification No.)

 

Bahnhofstrasse 21

Zug, Switzerland

  6300
(Address of Principal Executive Offices)   (Zip Code)

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

to be so Registered

 

Name of Each Exchange on Which

Each Class is to be Registered

Common shares, nominal value CHF 0.40 per share   The NASDAQ Stock Market LLC

 

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box.  x:

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box.  ¨

 

Securities Act registration statement file number to which this form relates:   

333-197105

(If applicable)

Securities to be registered pursuant to Section 12(g) of the Act:

(Title of Class)

N/A

 

 

 


Item 1: Description of Registrant’s Securities to be Registered

The description under the heading “Description of Share Capital and Articles of Association” relating to the Registrant’s common shares, CHF 0.40 nominal value per share (the “Common Shares”), in the prospectus included in the Registrant’s Registration Statement on Form F-1 (Registration No. 333-197105) originally filed with the Securities and Exchange Commission on June 27, 2014, as amended (the “Registration Statement”), is incorporated by reference herein. In addition, the description that will be included under the heading “Description of Share Capital and Articles of Association” relating to the Common Shares in the Registrant’s final prospectus relating to the Registration Statement to be subsequently filed with the Securities and Exchange Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, shall be incorporated by reference herein.

Item 2: Exhibits

Pursuant to the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.


SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

Auris Medical Holding AG
By:  

/s/ Thomas Meyer

Name:   Thomas Meyer
Title:   Chief Executive Officer

Date: July 29, 2014